Point72 Asset Management
RNAC icon

Point72 Asset Management’s Cartesian Therapeutics RNAC Stock Holding History

Point72 Asset Management’s Portfolio RNAC Stock Details RNAC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$244K Buy
2020
Q4 		– Sell
2020
Q3 		$992K Sell
2020
Q2 		$2.84M Buy
2020
Q1 		$2.08M Buy
2018
Q1 		– Sell
2017
Q4 		$982K Buy
2017
Q3 		– Sell
2017
Q2 		$2.38M Buy